A private affair
With the take-over of Boots the Chemist raising the temperature on the high street, the debate about whether investment by private equity companies is a good prescription or an asset-stripper for British companies is back on people's lips, as Veronica Cowan reports
Recent news stories on the take-over of Boots the Chemist have bought the argument about the pros and cons of private equity investment to the fore in the insurance market.
Mergers and acquisitions can
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe
You are currently unable to print this content. Please contact info@postonline.co.uk to find out more.
You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@postonline.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@postonline.co.uk
More on Commercial
Pen slims down leadership team ahead of MD’s retirement
Pen Underwriting has appointed Sarah Breslin as managing director of its new commercial UK & Ireland division.
LA blaze shows insurers must be agents of resilience
As the cost of fixing the damage done by the Los Angeles wildfires runs into billions of pounds, Rory Yates, global strategic lead at EIS, argues rather than retreat from risk claiming withdrawal is the only option, insurers must demonstrate every avenue for resolution has been pursued.
Bridgehaven on course to hit £400m GWP
Eighteen months on from launching the UK’s first hybrid fronting insurer in the summer of 2023, Bridgehaven founder Paul Jewell has revealed his business is on track to achieve £400m to £500m of gross written premium by the end of 2025.
Record claims payouts signal ‘new normal’ in W&I market
Howden has reported that its clients saw a record year of warranty and indemnity claims recoveries in 2024, with the business class seeing significantly elevated notifications for a second year in a row.
Enter Best Insurance Employer 2025 today
If you work for one of the greatest employers in the insurance industry and want to shout about it, make sure you complete Insurance Post’s Best Insurance Employer survey today.
Ecclesiastical detects more than £4m in false claims
Claims specialists at Ecclesiastical Insurance have uncovered £4m in fraudulent claims during 2024, almost £1m more than in 2023.
RSA and NIG’s David Enoch set to retire
RSA’s distribution and proposition director David Enoch is set to retire after five years at the insurer and its recent acquiree NIG.
Diary of an Insurer: Axa’s Paul Tombs
Paul Tombs, director of intermediated SME at Axa Commercial, catches up with his team in Glasgow, struggles to get his miniature dachshund Betty to go for a walk in the winter, and enjoys fajita Friday with his wife and twins.